Allergan plc (AGN) and Gedeon Richter Plc announced positive topline results for RGH-MD-53, a Phase 3 study of cariprazine for the treatment of adults with major depressive episodes associated with bipolar I disorder or bipolar I depression.
from RTT - Biotech https://ift.tt/2q41hd6
via IFTTT
No comments:
Post a Comment